Sentinel Initiative Public Workshop The Brookings Institution - PowerPoint PPT Presentation

Feb 10, 2024 •273 likes •316 views

Sentinel Initiative Public Workshop The Brookings Institution Marriott Wardman Park Washington, DC January 31, 2013 Development of the Sentinel System through Public-Private Collaboration FDA awards Mini-Sentinel Brookings able to query

Sentinel Initiative Public Workshop The Brookings Institution Marriott Wardman Park Washington, DC January 31, 2013
Development of the Sentinel System through Public-Private Collaboration FDA awards Mini-Sentinel Brookings able to query FDAAA convener grant Sentinel Initiative data from 126 announced million individuals FDA awards HPHC Brookings Brookings Brookings Mini-Sentinel Public Public Public contract Workshop Workshop Workshop FDASIA 2007 2008 2009 2010 2011 2012 2013 Brookings Brookings OMOP FDA awards 8 Public Public launched small project Workshop Workshop contracts Assessment Assessment completed: initiated: Angioedema events and Myocardial drugs that target the renin- Infarction and Oral angiotensin-aldosterone Hypoglycemics system
Public Workshop Agenda •The Sentinel Initiative: Ongoing Progress and Future Directions •State of Mini-Sentinel Activities •Selected Mini-Sentinel Protocol Driven Evaluations •Collaborations Supporting Active Surveillance Research •Planned Expansion of Prospective Surveillance Program •Opportunities to Expand the Public Health Impact of the Sentinel Initiative •Stakeholder Feedback: Mini-Sentinel as a Tool for Evaluating Drug Safety Issues that Require Regulatory Action

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Sentinel Initiative Public Workshop Monday, January 11, 2010 Mark McClellan, MD, PhD Director,

Sentinel Initiative Public Workshop Monday, January 11, 2010 Mark McClellan, MD, PhD Director, Engelberg Center for Health Care Reform Leonard D. Schaeffer Chair in Health Policy Studies The Brookings Institution Welcome The Food and Drug

543 views • 15 slides

FDA Mini-Sentinel as a National Resource Jeffrey Brown Harvard Pilgrim Health Care Institute

Opportunities to Expand the Public Health Impact of the Sentinel Initiative FDA Mini-Sentinel as a National Resource Jeffrey Brown Harvard Pilgrim Health Care Institute Harvard Medical School January 31, 2013 info@mini-sentinel.org 1 Outline

476 views • 16 slides

Bray Patrick-Lake, BS, MFS Disclosures FDA Patient Representative Mini-Sentinel National

Mini-Sentinel from Vision to Reality: A Patient Representatives Perspective Bray Patrick-Lake, BS, MFS Disclosures FDA Patient Representative Mini-Sentinel National Planning Board Clinical Trials Transformation Initiative Steering

204 views • 8 slides

Topics for Discussion What is a sentinel lymph node (SLN)? Utility of sentinel lymph biopsies:

5/17/2013 Topics for Discussion What is a sentinel lymph node (SLN)? Utility of sentinel lymph biopsies: therapeutic or staging? Thin Melanoma and Sentinel Node Dissection Groin Mapping Superficial/Deep Current Treatment of Timing of

581 views • 18 slides

SENTINEL TESTING, RESULTS TO DATE TOTAL NUMBERS: Inmates have been tested at the Butte

MONTANA DEPARTMENT OF CORRECTIONS + COVID-19 RESPONSE UPDATE LAW AND JUSTICE INTERIM COMMITTEE JUNE 30, 2020 + COVID-19 SENTINEL TESTING AT DOC FACILITIES + COVID-19 SENTINEL TESTING MAY 21, 2020 DOC started sentinel testing of

511 views • 12 slides

Mini-Sentinel Common Data Model Lesley Curtis on behalf of the Mini-Sentinel Data Core May 8,

Mini-Sentinel Common Data Model Lesley Curtis on behalf of the Mini-Sentinel Data Core May 8, 2013 info@mini-sentinel.org 1 Guiding principles (selected) Accommodates all requirements of Mini-Sentinel and can evolve to meet expanded

254 views • 10 slides

How CDER is Using Mini-Sentinel Tools and Resources for Post-Marketing Safety Issues Marsha E.

How CDER is Using Mini-Sentinel Tools and Resources for Post-Marketing Safety Issues Marsha E. Reichman, Ph.D. Scientific Lead for Surveillance Programs CDER Lead for the Sentinel Initiative OSE/CDER/FDA January 31, 2013 CDER use of

461 views • 17 slides

Sentinel Landscapes Sentinel Landscapes are working or natural lands important to the Nations

Sentinel Landscapes Sentinel Landscapes are working or natural lands important to the Nations defense mission places where preserving the working and rural character of key landscapes strengthens farms, ranches, and forests economically;

307 views • 11 slides

Status of Sentinel-1 and acquisition plans for GFOI Frank Martin Seifert, Pierre Potin, Johannes

Status of Sentinel-1 and acquisition plans for GFOI Frank Martin Seifert, Pierre Potin, Johannes Roeder, ESA Earth Observation Programme 5 th Space Data Coordination, ESRIN, Frascati, 24 February 2014 GMES Sentinel Missions Sentinel 1

268 views • 16 slides

Sentinel Mine & Enterprise Project Analyst presentation October 2015 1 Trident Project

Sentinel Mine & Enterprise Project Analyst presentation October 2015 1 Trident Project location 2 Orientation project layout YOU ARE HERE 3 Sentinel Mine 4 Total Sentinel capex $2.1billion Total Sentinel capex = approx

352 views • 33 slides

FDA's Mini Sentinel Program to FDA s Mini Sentinel Program to Evaluate the Safety of Marketed

FDA's Mini Sentinel Program to FDA s Mini Sentinel Program to Evaluate the Safety of Marketed Medical Products d l d Update and Focus on Communications Focus on Communications Richard Platt Harvard Pilgrim Health Care Institute Harvard

408 views • 29 slides

Leaders Meeting Sentinel event Annual report 2016-17 Overview Update re Incident Response Team

Quarterly Quality & Safety Leaders Meeting Sentinel event Annual report 2016-17 Overview Update re Incident Response Team Summary of Sentinel Event data 2013-2017 Overview of Sentinel Event data 2016/17 Ambitions for 2018+ Sentinel Event

235 views • 21 slides

Central Florida Water Initiative Rule Development Workshop July 9, 2020 Webinar Housekeeping

Central Florida Water Initiative Rule Development Workshop July 9, 2020 Webinar Housekeeping All participants are muted Webinar is being recorded Public Comment *6 to mute/unmute phone *Raise hand on the control panel 2 Workshop

549 views • 43 slides

Initiative for Public Health Outcomes (InPHORM) Public Health (PH) refers to all organized

11/09/2018 Initiative for Public Health Outcomes (InPHORM) Pilot Outreach Initiative for Public Health Outcomes (InPHORM) Public Health (PH) refers to all organized measures, both public and private, to prevent disease, promote health,

433 views • 3 slides

An OSSE to Study the Impact of Sentinel S4, S5 and S5P spaceborne Observations on Air Quality

An OSSE to Study the Impact of Sentinel S4, S5 and S5P spaceborne Observations on Air Quality Data Assimilation Systems Henk Eskes, KNMI, The Netherlands, ISOTROP project partners, ESA OSSE workshop, ECMWF, 9-11 Nov 2016 1 The ISOTROP

674 views • 31 slides

SPI ALBANIA AN INITIATIVE FOR ALBANIA FINANCIAL SECTOR MODERNIZATION Public-Private Dialogue

SPI ALBANIA AN INITIATIVE FOR ALBANIA FINANCIAL SECTOR MODERNIZATION Public-Private Dialogue Vienna Global Workshop April 28-30, 2009 By Ramona Bratu, World Banks Convergence Program, SPI Regional Operations Director SPI ALBANIA

580 views • 8 slides

The STARS Paper The Paper and the Process Your job while you are here: 1. Learn the process of

The STARS Paper The Paper and the Process Your job while you are here: 1. Learn the process of doing scientific research 2. Compile your data in the form of a scientific research article 3. Make friends and have fun How do you accomplish this:

500 views • 13 slides

Luis Ruilope, Unidad de Hipertension Madrid, Spain Cardio-renal continuum REGRESS Target organ

Asian Chapter Asian Chapter Achieving Blood Pressure targets: Current & future options in blocking the Renin Angiotensin System Luis Ruilope, Unidad de Hipertension Madrid, Spain Cardio-renal continuum REGRESS Target organ damage

465 views • 18 slides

$Lights, Cam era, ( Vaso) Action! Vasoactive Agents for Catecholam ine Refractory Septic Shock$

Lights, Cam era, ( Vaso) Action! Vasoactive Agents for Catecholam ine Refractory Septic Shock

Lights, Cam era, ( Vaso) Action! Vasoactive Agents for Catecholam ine Refractory Septic Shock Gregory Kelly, Pharm.D. PGY2 Emergency Medicine Pharmacy Resident University of Rochester Medical Center October 28, 2017 Conflicts of I nterest I

857 views • 52 slides

Disclaimer This presentation document has been prepared by Renalytix AI plc ("RenalytixAI )

Disclaimer This presentation document has been prepared by Renalytix AI plc ("RenalytixAI ) for information purposes only in relation to the proposed restricted offer of ordinary shares to certain qualifying shareholders of EKF Diagnostics

624 views • 23 slides

MACRA: Preparing for the Road Ahead George Mayzell, MD MBA Chief Clinical Officer MACRA George

MACRA: Preparing for the Road Ahead George Mayzell, MD MBA Chief Clinical Officer MACRA George Mayzell, M.D. DISCLOSURE: In accordance with the guidelines of the Florida Medical Association/Accreditation Council for Continuing Medical

521 views • 48 slides

What is Peripheral Vascular Disease? Any vascular disease that isnt in the heart Areas

10/10/2015 Peripheral Vascular Disease Ganesh Muthappan, MD, FACC Disclosures I work for St. Charles Heart and Lung Center I am trying to build a practice in central Oregon I do own a small amount of St. Jude stock as part of a

676 views • 25 slides

DEVELOPING NOVEL, FIRST-IN-CLASS CARDIOVASCULAR DRUGS Corporate Presentation April 2019

DEVELOPING NOVEL, FIRST-IN-CLASS CARDIOVASCULAR DRUGS Corporate Presentation April 2019 Disclaimer This presentation and the information contained herein does not constitute or form part of, and should not be construed as, an offer or

568 views • 32 slides

Elevated alkaline phosphatase: The initial laboratory abnormality in an atypical presentation of

International Journal of Clinical Rheumatology Case Report Elevated alkaline phosphatase: The initial laboratory abnormality in an atypical presentation of Takayasu Arteritis Ambreesh Chawla 1 *, Background: Takayasu Arteritis rarely presents

304 views • 4 slides